Search PubMed⌕ Search

Biomedical subjects

D A Price

Publications and source records attributed to D A Price.

299 records · Page 17Linked to original sources
PubMedDate not supplied

Quantitative assessment of cortical synaptic density in Alzheimer's disease.

Significant progress has been made over the last decade in delineating the neuropathological and neurochemical changes in the brains of patients with Alzheimer's disease (AD). Less well studied are the actual synaptic connections of affected areas of the brain, such as the cerebral cortex. Because the final common pathway for neurotransmission involves synaptic integrity, we quantitatively assessed synaptic number and synapse size in lamina III and V of human frontal cortex (Brodmann area 9) in patients with AD and age-matched controls. Samples were also matched for postmortem interval, and artifacts associated with postmortem change were eliminated. We found a significant decrease in synaptic number per unit volume in both lamina, more marked in lamina III (-42%) than V (-29%). In both normal controls and AD brains, there was a negative correlation between synapse number and synapse size as indexed by the length of the postsynaptic density (PSD); cortical samples with fewer synapses had larger synapse size. This appeared to be a compensatory response, rather than a selective loss of small synapses, since the total amount of synaptic contact area per unit volume did not decline in lamina V (despite a 29% loss of synapses); in lamina III it was reduced 11% despite a 42% loss of synapses. The loss of synapses in AD is widespread and significant in frontal cortex; there is observable compensation by enlargement of synaptic size. This compensatory effort is overcome by the continuing loss of synapses in areas most affected by the degeneration.

Aged↗
PubMedDate not supplied

Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex.

To investigate possible age-associated changes in human synaptic connectivity, superior-middle frontal cortex (Brodmann area 9) was evaluated with ultrastructural techniques. Short post mortem autopsy tissue was obtained from 37 cognitive normal individuals ranging in age from 20 to 89 years. A minimum of five subjects represented each decade of life. Synaptic volume density (Nv) was quantified in lamina III and V of the superior-middle frontal cortex employing the physical disector. The stereological assessment demonstrated maintenance of Nv in both lamina III and V of the frontal cortex. The lack of synaptic decline in the frontal cortex in neurologically normal individuals older than 65 years lends support to the idea that many stereotypic views of age-related changes in the CNS do not apply to all brain regions. It also suggests that synaptic loss observed in pathological conditions such as Alzheimer's disease, may be the result of the disease process and not a consequence of normal aging.

Adult↗
PubMedDate not supplied

Short-term growth in children with growth disorders.

OBJECTIVE: We have previously demonstrated that normal prepubertal growth over 1 year is composed of growth spurts lasting an average of 8 weeks, separated by periods of very slow growth or stasis. We have now analysed short-term growth patterns in eight children with different growth disorders: Turner syndrome (n = 2), intrauterine growth retardation (IUGR, n = 1) and growth hormone (GH) deficiency (GHD, n = 5). METHODOLGY: Height was measured daily in the morning by parents over 4-12 months. Regression and time series analysis were used to characterize short-term growth. In two boys (GHD and IUGR) their normal twin brother was measured in parallel. RESULTS: All height velocity curves, based on regression analysis, showed a biphasic pattern, characterized by growth spurts of varying amplitudes and periods of very slow growth or growth stasis. When compared to growth curves in normal children, the principal qualitative differences in GHD and Turner syndrome were increased stasis time and reduced growth spurt amplitude. In IUGR reduced amplitude and length of growth spurts were seen, but the time spent in stasis was similar to normal children. Two naive patients with GHD increased the amplitude of their growth spurts by a mean 0.013 cm day(-1) on GH treatment, with the mean length of their growth spurts increasing by 10 days. Their time spent in stasis decreased from 19% to 6% on GH. In two subjects with GHD the growth pattern during maintenance GH treatment was similar to that seen in normal children. Using time series analysis significant periodicities in height measurements were seen in the majority of children with growth disorders, which disappeared in patients with GHD in the catch-up phase after commencing GH therapy. CONCLUSIONS: (1) The growth spurts and stases seen in normal children are also observed in those with growth disorders, (2) different growth disorders have variable effects on the spurt stasis model of childhood growth, (3) catch-up growth on GH in children with GHD was achieved by increasing the amplitude of the growth spurts and reducing the time spent in stasis.

Body Height↗
PubMedDate not supplied

Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease.

We quantified the synaptic density in the outer molecular layer of the hippocampal dentate gyrus. Autopsy material from 9 individuals with Alzheimer disease (AD) were compared to 10 age-matched, postmortem-matched controls without dementia, using standard electron microscopy. Statistical analyses showed a significant change in the density of synapses between controls and AD subjects. There was a significant decline in the width of the entire molecular layer in the AD material. Synaptic density showed a significant correlation with synaptic apposition length in both AD and control groups. As the number of synapses declined, the synaptic apposition length increased. The decline in density of synapses in the AD group might reflect the degree of neuronal loss in the entorhinal cortex. Such a loss in synaptic connectivity could play a key role in memory-related problems associated with AD.

Aged↗
PubMedDate not supplied

Gonadotrophin-independent precocious puberty and dyschondrosteosis.

We present a case of gonadotrophin-independent precocious puberty, as seen in McCune-Albright syndrome, and Leri-Weill dyschondrosteosis in a six and a half year-old girl. Her father also reports having early puberty and is similarly affected with dyschondrosteosis. This combination of features has not been reported previously, and represents the association of a skeletal dysplasia with an endocrinopathy.

Bone Diseases, Developmental↗
PubMedDate not supplied

Magnetic resonance imaging of the hypothalamic-pituitary axis in the diagnosis of growth hormone deficiency.

In order to investigate the relationship between pituitary appearance and the diagnosis of growth hormone deficiency (GHD), we have assessed magnetic resonance imaging (MRI) scans and GH status during provocation tests in 110 patients (78 males; median age 9.8, range 0.1-20 yr), evaluated for possible GH disorders. On the basis of pituitary function tests, patients were divided into GH deficient (GH peak < 15 mIU/l [5.8 ng/ml]) (n = 82) or GH sufficient (GH peak > 15 mIU/l) (n = 28). The former were further divided into those with multiple hormone deficits (MPHD) (n = 19) or isolated GHD - severe IGHD (peak GH < 8 mIU/l [3.1 ng/ml]) or partial IGHD (8-15 mIU/l). The appearance of the hypothalamic-pituitary (H-P) axis was classified as: (1) normal, (2) isolated hypoplastic stalk (HPS), (3) isolated hypoplastic anterior lobe (HPAL) (PHT SDS < -2.0), (4) HPS + HPAL or (5) ectopic posterior lobe (EPL). The last two were considered severe abnormalities. PHT SDS (mean +/- SD -2.0 +/- 2.2) was correlated to log peak GH levels in the whole group (r = 0.45; p < 0.0001) and in the GHD group (r = 0.39; p < 0.0001). Sixty-five out of 82 in the GHD group had a H-P axis abnormality (45 severe abnormalities), while 13 out of the 28 patients in the GH sufficient group also had an abnormality (3 severe, but none with an EPL). All patients with MPHD had a MRI abnormality, most commonly an EPL (79%). Thus the presence of any MRI abnormality as a marker for GHD would generate a sensitivity of 79%, but a specificity of only 54%, indicating that this could not be used to confirm GHD. However, the presence of either an EPL or HPS + HPAL on MRI is highly specific (100% and 89% respectively) and predictive of GHD (positive predictive value 100% and 79% respectively), indicating that these abnormalities provide confirmation of the diagnosis. We recommend that if clinical, auxological and biochemical data indicate a diagnosis of GHD, then a MRI scan should be undertaken to define the pituitary anatomy and to help confirm the diagnosis.

Adolescent↗
PubMedDate not supplied

Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction.

Marked disturbance in eating behaviour and obesity are common sequelae of hypothalamic damage. To investigate whether these were associated with dysfunctional leptin central feedback, we evaluated serum leptin and leptin binding activity in 37 patients (age 3.5-21 yr) with tumour or trauma involving the hypothalamic-pituitary axis compared with 138 healthy children (age 5.0-18.2 yr). Patients were subdivided by BMI <2 SDS or > or = 2 SDS and healthy children and children with simple obesity of comparable age and pubertal status served as controls. Patients had higher BMI (mean 1.9 vs 0.2 SDS; p <0.001), a greater proportion had BMI > or = 2 SDS (54% vs 8%; p <0.001) and higher serum leptin (mean 2.1 vs 0.04 SDS; p <0.001) than healthy children. Serum leptin (mean 1.1 vs -0.1 SDS; p = 0.004) and values adjusted for BMI (median 0.42 vs 0.23 microg/l:kg/m2; p = 0.02) were higher in patients with BMI <2 SDS. However, serum leptin adjusted for BMI was similar in patients with BMI > or = 2 SDS compared to corresponding controls (1.08 vs 0.95; p = 0.6). Log serum leptin correlated with BMI SDS in all subject groups but the relationship in patients with BMI <2 SDS was of higher magnitude (r = 0.65, slope = 0.29, p =0.05 for difference between slopes) than in healthy controls (r = 0.42, slope = 0.19). Serum leptin binding activity (median 7.5 vs 9.3%; p = 0.02) and values adjusted for BMI (median 0.28 vs 0.48 % x m2/kg; p <0.001) were lower in patients than in healthy children. The markedly elevated leptin levels with increasing BMI in non-obese patients with hypothalamic-pituitary damage are suggestive of an unrestrained pattern of leptin secretion. This along with low leptin binding activity and hence higher free leptin levels would be consistent with central leptin insensitivity.

Adipose Tissue↗